A Systematic Overview of Radiation Therapy Effects in Rectal Cancer

References

• Stenbeck M, Rosen M, Holm L-E. Cancer survival in Sweden during three decades 1961-1991. Acta Oncol 1995; 34: 881–91. (01)
   Google Scholar
• Dahlberg M, Glimelius B, Bergstrom R, Pahlman L. Im-proved survival in patients with rectal cancer: a population based register study. Br J Surg 1998; 85: 515-20. (01)
   Google Scholar
• Lehander Martling A, Holm T, Rutqvist L-E, Moran BJ, Heald RJ, Cedermark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 2000; 356: 93-6. (R1/447)
   Google Scholar
• Camilleri-Brennan J, Steele RJ. The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol 2001; 27: 349–53. (P1/25)
   PubMed Web of Science ®Google Scholar
• Blomgren H. Rectal cancer. Acta Oncol 1996; 35 (Suppl 7): 64–74.
   PubMed Web of Science ®Google Scholar
• Boulis-Wassif S. The role of pre-operative adjuvant therapy in the management of borderline operability rectal cancer. Clin Radiol 1982; 33: 353-8. (C3/109)
   Google Scholar
• Rider WD, Palmer JA, Mahoney LJ, Robertson CT. Pre-operative irradiation in operable cancer of the rectum: report of the Toronto trial. Can J Surg 1977; 20: 335-8. (C3/106)
   Google Scholar
• Duncan W, Smith AN, Freedman LS, Alderson MR, Arnott SJ, Bleehen NM. The evaluation of low dose pre-operative x-ray therapy in the management of operable rectal cancer, results of a randomly controlled trial. Br J Surg 1984; 71: 21-5. (C1/824)
   Google Scholar
• Sause WT, Pajak TF, Noyes RD, et al. Evaluation of preoperative radiation therapy in operable colorectal cancer. Ann Surg 1994; 220: 668-75. (C3/77)
   Google Scholar
• Goldberg PA, Nicholls RJ, Porter NH, Love S, Grimsey JE. Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer 1994; 30A: 1602-6. (C2/468)
   Google Scholar
• Marsh PJ, James RD, Schofield PF. Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective, randomized trial. Dis Colon Rectum 1994; 37: 1205-14. (C1/284)
   Google Scholar
• Stockholm Rectal Cancer Study Group. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer 1990; 66: 49-55. (C1/ 849)
   Google Scholar
• Swedish Rectal Cancer Trial. Improved survival with pre-operative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336: 980-7. (C1/1147)
   Google Scholar
• Gerard A, Buyse M, Nordlinger B, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Ann Surg 1988; 208: 606-14. (C1/466)
   Google Scholar
• Horn A, Halvorsen JF, Dahl O. Preoperative radiotherapy in operable rectal cancer. Dis Colon Rectum 1990; 33: 823-38. (C2/269)
   Google Scholar
• Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 1996; 348: 1605-10. (C2/279)
   Google Scholar
• Niebel W, Schultz U, Ried M, et al. Five-year results of a prospective randomised study: experience with combined radiotherapy and surgery for primary rectal carcinoma. Recent Results Cancer Res 1988; 110: 111-3. (C3/142)
   Google Scholar
• Higgins G, Humphrey E, Dwight R, Roswit B, Lee L, Keehn R. Preoperative radiation and surgery for cancer of the rectum. VASOG Trial II. Cancer 1986; 58: 352-9. (C3/361)
   Google Scholar
• Roswit B, Higgins G, Keehn R. Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: report of a National Veterans Administration randomized study. Cancer 1975; 35: 1597-602. (C3/613)
   Google Scholar
• Kligerman MM. Preoperative radiation therapy in rectal cancer. Cancer 1975; 36: 691-5. (C3/31)
   Google Scholar
• Kutzner J, Bruckner R, Kempf P. Preoperative radiotherapy in rectal cancer. Strahlentherapie 1984; 160: 236-8. (C3/170)
   Google Scholar
• Reis Neto JA, Quilici FA, Reis Jr JA. A comparison of nonoperative vs preoperative radiotherapy in rectal carci-noma. A 10-year randomized trial. Dis Colon Rectum 1989; 32: 702–10. (C3/68)
   Google Scholar
• Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al. Preopera-tive radiotherapy in combination with total mesorectal excision improves local control in resectable rectal cancer. Report from a multicenter randomized trial. For the Dutch Colo Rectal Cancer Group and other cooperative investiga-tors. New Engl J Med 2001; 345: 638-46. (C1/1861)
   Google Scholar
• Stearns MW, Deddish MR, Quan SHQ, Leaming RH. Preoperative roentgen therapy for cancer of the rectum and rectosigmoid. Surg Gynecol Obstet 1974; 138: 584-6. (C3/ 790)
   Google Scholar
• Balslev I, Pedersen M, Teglbjaerg PS, et al. Postoperative radiotherapy in Dukes' B and C carcinoma of rectum and rectosigmoid. Cancer 1986; 58: 22-8. (C1/494)
   Google Scholar
• Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 1996; 348: 1610-4. (C1/469)
   Google Scholar
• Arnaud JP, Nordlinger B, Bosset JF, et al. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer. Br J Surg 1997; 84: 352-7. (C3/170)
   Google Scholar
• Treurniet-Donker AD, J van Putten WL, Wereldsma JCJ, et al. Postoperative radiation therapy for rectal cancer. Cancer 1991; 67: 2042–8. (C3/172)
   Google Scholar
• Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. New Engl J Med 1985; 312: 1465-72. (C3/202)
   Google Scholar
• Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP Protocol R-01. J Natl Cancer Inst 1988; 80: 21-9. (C1/555)
   Google Scholar
• Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000; 92: 388-96. (C1/741)
   Google Scholar
• Marneghan H, Gray BN, de Zwart J, et al. Adjuvant post-operative radiotherapy in rectal cancer: results from the ANZ bowel cancer trial (Protocol 8202). Australas Radiol 1991; 35: 61-5. (C3/33)
   Google Scholar
• Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal cancer. New Engl J Med 1991; 324: 709-15. (C2/204)
   Google Scholar
• Tveit KM, Guldvog I, Hagen S, et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treat-ment of Dukes' B and C rectal cancer. Br J Surg 1997; 84: 1130-5. (C2/144)
   Google Scholar
• O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994; 331: 502-7. (C1/660)
   Google Scholar
• Mansour EG, Lefkopoulou M, Johnson R, Douglass H. A comparison of postoperative adjuvant chemotherapy, radio-therapy or combination therapy in potentially curable resect-able rectal carcinoma. An ECOG study Est 4276. Proc Am Soc Clin Oncol 1991; 10: 154 abstr. (C3/237)
   Google Scholar
• Fountzilas G, Zisiadis A, Dafni U, et al. Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a rando-mized phase III study conducted by the Hellenic Cooperative Oncology Group. Ann Oncol 1999; 10: 671-6. (C3/220)
   Web of Science ®Google Scholar
• Tepper JE, O'Connell MJ, Petroni GR, et al. Adjuvant postoperative fluourouracil-modulated chemotherapy com-bined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. J Clin Oncol 1997; 15: 2030-9. (C1/1696)
   Google Scholar
• Tepper JE, O'Connell M, Niedzwiecki D, et al. Final Report of INT 0114 - adjuvant therapy in rectal cancer: analysis by treatment, stage and gender. Proc Am Soc Clin Oncol 2001; abstr 489. (C3/1792)
   Google Scholar
• Gastrointestinal Tumor Study Group. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 1992; 10: 549-57. (C1/660)
   Google Scholar
• Lee J-H, Lee J-H, Ahn J-H, et al. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: A preliminary report. J Clin Oncol 2002; 20: 1751–8. (C2/274)
   Google Scholar
• Frykholm G, Glimelius B, Pahlman L. Pre- or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993; 36: 564–72. (CU 471)
   Google Scholar
• Hyams DM, Masounas EP, Petrelli N, et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. A progress report of the National Surgical Adjuvant Breast and Bowel Project protocol R-03. Dis Colon Rectum 1997; 40: 131–9. (C3/116)
   Google Scholar
• Roh M, Petrelli N, Wieand S, et al. Phase III randomised trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03). Proc Am Soc Clin Oncol 2001; abstr 490. (C3/267)
   Google Scholar
• Sauer R, Fietkau R, Wittekind C, et al. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol 2001; 177: 173–81. (C3/628, ongoing)
   Google Scholar
• Bosset JF, Horiot JC, Hamers HP, et al. Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group. Radiother Oncol 2001; 61: 7-13.(C1/484)
   Google Scholar
• Colorectal Cancer Collaborative Group. Adjuvant therapy for rectal cancer: a systematic overview of 8 507 patients from 22 randomised trials. Lancet 2001; 358: 1291-304. (M1/8507)
   Google Scholar
• Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA 2000; 284: 1008-15. (M2/5974)
   Google Scholar
• Munro AJ, Bentley AHM. Adjuvant radiotherapy in operable rectal cancer: a systematic review. Sem Colon & Rectal Surg 2002; 13: 31-42. (M1/9371)
   Google Scholar
• Gerard J-P, Baulieux J, Francois Y, et al. The role of radiotherapy in the conservative treatment of rectal carci-noma. Acta Oncol 1998; 37: 247–52. (L1)
   Google Scholar
• Enker WE. Total mesorectal excision - the new golden standard of surgery for rectal cancer. Ann Med 1997; 29: 127-33. (01)
   PubMed Web of Science ®Google Scholar
• MacFarlane JK, Rya11 RDH, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-60. (01)
   Google Scholar
• Havenga K, Enker WE, Norstein J, et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1 411 patients. Eur J Surg Oncol 1999; 25: 368-74. (R1/1411)
   Google Scholar
• Dahlberg M, Glimelius B, Pahlman L. Changing strategy for rectal cancer is associated with improved outcome. Br J Surg 1999; 86: 379-84. (R1/423)
   Google Scholar
• Wibe A, Moller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45: 857–66.
   PubMed Web of Science ®Google Scholar
• Arbman G, Nilsson E, Hallbook O, Sjodahl R. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996; 83: 375-9. (02)
   Google Scholar
• Machado M, Goldman S, Järhult J. Improved results in rectal cancer surgery - an effect of specialization? Colorectal Dis 2001; 2: 264-9. (L2)
   Google Scholar
• McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. Br Med J 1991; 302: 1501-5. (0)
   Google Scholar
• Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeon-related factors and outcome in rectal cancer. Ann Surg 1998; 227: 157–67.
   PubMed Web of Science ®Google Scholar
• Herrmann T, Petersen S, Hellmich G, Baumann M, Ludwig K. Spättoxizität nach präoperativer Kurzzeitvorbestrahlung und risikoadaptierter postoperativer Nachbestrahlung bei operablem Rektumkarzinom. Strahlenter Onkol 1999; 175: 430-6. (C3/77)
   Google Scholar
• Glimelius B, Isacsson U, Jung B, Pahlman L. Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favouring preoperative treatment. Int J Radiat Oncol Biol Phys 1997; 37: 281-7. (01)
   Google Scholar
• Suwinski R, Taylor JMG, Withers HR. Rapid growth of microscopic rectal cancer as a determinant of response to preoperative radiation therapy. Int J Radiat Oncol Biol Phys 1998; 42: 943-51. (R1/3338)
   Google Scholar
• NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990; 264: 1444-50. (01)
   Google Scholar
• Cafiero F, Gipponi M, Peressini A, Bertoglio S, Lionetto R. Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-FU and levamisole in patients with TNM stage II-III resectable rectal cancer. J Surg Oncol 2000; 75: 80–8. (C3/218)
   Google Scholar
• Ragnhammar P, Hafström Lo, Nygren P, Glimelius B. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 2001; 40: 282-308. (01)
   Google Scholar
• Nygren P, Glimelius B. The Swedish Council on Technology Assessment in Health Care (SBU) report on Cancer Chemotherapy-project objectives, the working process, key definitions and general aspects on cancer trial methodology and interpretation. Acta Oncol 2001; 40: 155-65. (01)
   Google Scholar
• Letschert JGJ, Lebesque JV, de Boer RW, Hart AAM, Bartelink H. Dose-volume correlation in radiation-induced late small-bowel complications: a clinical study. Radiother Oncol 1990; 18: 307-20. (01)
   Google Scholar
• Frykholm-Jansson G, Isacsson U, Sintorn K, et al. Preopera-tive radiotherapy in rectal carcinoma - aspects of adverse effects and radiation technique. Int J Radiat Oncol Biol Phys 1996; 35: 1039–48. (01)
   Google Scholar
• Rouanet P, Fabre JM, Dubois JB, et al. Conservative surgery for low rectal carcinoma after high-dose radiation: functional and oncologic results. Ann Surg 1995; 221: 67-73. (P2/37)
   Google Scholar
• Swedish Rectal Cancer Trial. Preoperative irradiation fol-lowed by surgery vs surgery alone in resectable rectal carcinoma - postoperative morbidity and mortality in a Swedish multicenter trial. Br J Surg 1993; 80: 1333–6. (CU 1147)
   Google Scholar
• Holm T, Rutqvist LE, Johansson H, Cedermark B. Post-operative mortality in rectal cancer treated with or without preoperative radiotherapy: causes and risk factors. Br J Surg 1996; 83: 964-8. (C1/1027)
   Google Scholar
• Holm T, Singnomklao T, Rutqvist L, Cedermark B. Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials. Cancer 1996; 78: 968-76. (C1/1027)
   Google Scholar
• Bubrik MP, Rolfmeyers ES, Schauer RM, et al. Effects of high-dose and low-dose preoperative irradiation on low anterior anastomosis in dogs. Dis Colon Rectum 1982; 25: 406-15. (01)
   PubMed Web of Science ®Google Scholar
• De Meerleer G, Pattyn P, Fortan L, et al. High-dose preoperative radiotherapy does not alter the strength of unilaterally irradiated colon anastomoses in rats. Int J Radiat Oncol Biol Phys 1999; 44: 163-70. (01)
   PubMed Web of Science ®Google Scholar
• Frykholm-Jansson G, Sintorn K, Montelius A, Jung B, Pahlman L, Glimelius B. Acute lumbosacral plexopathy after preoperative radiotherapy in rectal carcinoma. Radiother Oncol 1996; 38: 121–30. (R1/550)
   Google Scholar
• Miller RC, Martenson JA, Sargent DJ, Kahn MJ, Krook JE. Acute treatment-related diarrhea during postoperative adju-vant therapy for high-risk rectal carcinoma. Int J Radiat Oncol Biol Phys 1998; 41: 593-8. (C1/204)
   Google Scholar
• Gunderson LL, Russell AH, Llewellyn HJ, Doppke KP, Tepper JE. Treatment planning for colorectal cancer: radia-tion and surgical techniques and value of small-bowel films. Int J Radiat Oncol Biol Phys 1985; 11: 1379-93. (01)
   Google Scholar
• Trimbos JB, Snijders G, Keilhold T, Peters AA. Feasibility of application of a resorbable polyglycolic-acid mesh (Dexonmesh) to prevent complications of radiotherapy following gynecological surgery. Eur J Surg 1991; 157: 281-4. (02)
   Google Scholar
• Mak AC, Rich TA, Schultheiss TE, Kavanagh B, Ota DM, Rosmdahl MM. Late complications of postoperative radia-tion therapy for cancer of the rectum and rectosigmoid. Int J Radiol Oncol Biol Phys 1994; 28: 597-603. (01)
   Google Scholar
• Kollmorgen CF, Meagher AP, Wolff BG, Pemberton JH, Matenson JA, Ilstrup DM. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 1994; 220: 676-82. (R3/100)
   Google Scholar
• Lewis WG, Williamson MER, Stephenson BM, et al. Poten-tial disadvantages of postoperative adjuvant radiotherapy after anterior resection for rectal cancer: a pilot study of sphincter function, rectal capacity and clinical outcome. Int J Colorectal Disease 1995; 10: 133-7. (L2)
   Google Scholar
• Lundby L, Jensen VJ, Overgaard J, Lauerberg S. Long-term colorectal function after postoperative radiotherapy for color-ectal cancer. Lancet 1997; 350: 564. (R2/84)
   Google Scholar
• Dahlberg M, Glimelius B, Graf W, Pahlman L. Preoperative irradiation affects the functional results after surgery for rectal cancer. Dis Colon Rectum 1998; 41: 543-9. (C1/203)
   Google Scholar
• Lundby L, Krogh K, Qvist N, et al. Severe late anorectal radiation morbidity following postoperative radiotherapy for rectal cancer-longtime results from a randomized trial. Radiother Oncol 2000; 57 (Suppl 1): abstr 25. (R3/84)
   Google Scholar
• Beets-Tan R, Beets G, Vliegen R, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357: 497–504. (01)
   Google Scholar
• Moertel CG, Childs DS Jr, Reitemeier RJ, et al. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969; 2: 865-7. (C3/65)
   Google Scholar
• Rominger CJ, Gelber RD, Gunderson LL, Conner N. Radiation therapy alone or in combination with chemother-apy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery. Radiation Therapy Oncology Group study (76-16). Am J Clin Oncol 1985; 8: 118–27. (C3/147)
   PubMed Web of Science ®Google Scholar
• Overgaard M, Bertelsen K, Dalmark M, et al. A randomized feasibility study evaluating the effect of radiotherapy alone or combined with 5-fluorouracil in the treatment of locally recurrent or inoperable colorectal carcinoma. Acta Oncol 1993; 32: 547-53. (C3/59)
   Google Scholar
• Danjoux CE, Gelber RD, Catton GE, Klaassen DJ. Combi-nation chemoradiotherapy for residual, recurrent or inoper-able carcinoma of the rectum: ECOG study (EST 3276). Int J Radiat Oncol Biol Phys 1985; 11: 765-71. (C3/30)
   Google Scholar
• Minsky BD, Cohen AM, Kemeny N, et al. The efficacy of preoperative 5-fluorouracil, high dose leucovorin and sequen-tial radiation therapy for unresectable rectal cancer. Cancer 1993; 71: 3486-92. (P2/20)
   Google Scholar
• Marsh R de W, Chu NM, Vauthey JN, et al. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy. Cancer 1996; 78: 217-25. (P3/18)
   Google Scholar
• De La Tone A, Ramos S, Valcárcel F, et al. Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1999; 45: 629-34. (P2/25)
   Google Scholar
• Mohiuddin M, Regine WF, John WJ, et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys 2000; 46: 883-8. (P2/33)
   Google Scholar
• Videtic GMM, Fisher BJ, Perera FE, et al. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1998; 42: 319-24. (P2/29)
   Google Scholar
• Frykholm G, Glimelius B, Pahlman L. Preoperative irradia-tion with and without chemotherapy (MFL) in the treatment of primary non-resectable adenocarcinoma of the rectum. Results from two consecutive studies. Eur J Cancer Clin Oncol 1989; 25: 1535-41. (P1/59)
   Google Scholar
• Chan A, Wong A, Langevin J, et al. Preoperative concurrent 5-FU infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 1993; 25: 791-9.(P2 /46)
   Google Scholar
• Chan AKP, Wong AO, Langevin J, et al. Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study. Int J Radiat Oncol Biol Phys 2000; 48: 843-56. (P1/156)
   Google Scholar
• Chan AKP, Wong AO, Langevin JM, et al. 'Sandwich' preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival. Int J Radiat Oncol Biol Phys 1997; 37: 629-37. (P2/27)
   Google Scholar
• Movsas B, Hanlon AL, Lanciano R, et al. Phase I dose escalating trial of hyperfractionated pre-operative chemora-diation for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 1998; 42: 43-50. (P3/27)
   Google Scholar
• Thrall MM, Wood P, King V, Rivera W, Hrushesky W. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with con-current radiation therapy in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2000; 46: 873–81. (R3/26)
   Google Scholar
• Bosset JF, Magnin V, Maingon P, et al. Preoperative radio-chemotherapy in rectal cancer: long-term results of a phase II trial. Int J Radiat Oncol Biol Phys 2000; 46: 323-7. (P1/66)
   Google Scholar
• Bosset JF, Pavy JJ, Hamers HP, et al. Determination of the optimal dose of 5-fluorouracil when combined with low dose d, 1-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. EORTC Radiotherapy Group. Eur J Cancer 1993; 10: 1406-10. (P1/85)
   Google Scholar
• Pfeiffer P, Jakobsen A. Concurrent UFT/1-leucovorin and high-dose radiotherapy (60 Gy) in patients with locally avanced rectal cancer (LARC): a phase I/II trial. Proc 11th NCl/EORTC/AACR Symp 2000; Amsterdam: 374 abstr. (P3/ 18)
   Google Scholar
• Hoff PM, Janjan N, Saad ED, et al. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer. J Clin Oncol 2000; 18: 3529-34. (P3/15)
   Google Scholar
• Mehta V, Fisher G, Ford J, Edelstein P, JP. Preoperative chemoradiotherapy for ultrasound staged T3, T4 or N+ rectal cancer. 6th Int Congr Radiat Oncol Radiother Oncol 2001; 58: 123 abstr. (P3/28)
   Google Scholar
• Dotor E, Munoz-Medina M, Navarro M, et al. Preoperative chemoradiotherapy (CHT-RDT) in locally advanced rectal cancer. Preliminary results. Ann Oncol 2000; 11: 230P abstr. (P3/90)
   Google Scholar
• Botwood N, James R, Vernon C, Price P. Raltitrexed (`Tomudex') and radiotherapy can be combined as post-operative treatment for rectal cancer. Ann Oncol 2000; 11: 1023-8. (P3/22)
   Web of Science ®Google Scholar
• Carraro S, Roca E, Cartelli C, et al. Unresectable rectal cancer (URC): Oxaliplatin (OXA), 5-fluorouracil (5-FU) and leucov-orin (LV) with concurrent radiotherapy (RT) followed by surgery. Preliminary results. Ann Oncol 2000; 11: 208 abstr. (P3/27)
   Google Scholar
• Jansson-Frykholm G, PhIlman L, Glimelius B. Combined chemo- and radiotherapy vs radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 2001; 50: 427–34. (C3/ 70)
   Google Scholar
• Anscher MS, Lee C, Hurwitz H, et al. A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer. Int J Radiat Oncol Biol Phys 2000; 47: 719-24. (P3/15)
   Google Scholar
• Rodel C, Grabenbauer GG, Matzel KE, et al. Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 2000; 43: 312-9. (P2/35)
   Google Scholar
• Tveit KM, Wiig JN, Olsen DR, Storaas A, Poulsen JP, Giercksky K-E. Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer. Radiother Oncol 1997; 44: 277-82. (P1/115)
   Google Scholar
• Moertel CG, Gunderson LL, Cohen AM, et al. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual or recurrent gatrointestinal carcinoma. J Clin Oncol 1994; 12: 21-7. (P3/10)
   Google Scholar
• Harrison LB, Minsky BD, Enker WE, et al. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. Int j Radiat Oncol Biol Phys 1998; 42: 325-30. (P1/112)
   Google Scholar
• Freyer G, Bossard N, Romestaing P, et al. Addition of oxaliplatin to continuous fluorouracil, 1-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial. J Clin Oncol 2001; 19: 2433-8. (P3/17)
   Google Scholar
• Allal AS, Bieri S, Pelloni A, et al. Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasi-bility, oncologic results and quality of life outcomes. Br J Cancer 2000; 82: 1131-7. (R1/53)
   Google Scholar
• Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999; 17: 2396-402. (C2/201)
   Google Scholar
• Bujko K, Nowacki M, Oledzki J, Sopylo R, Skoczylas J, Chwalinsky M. Sphincter preservation after short-term pre-operative radiotherapy for low rectal cancer. Presentation of own data and a literature review Acta Oncol 2001; 40: 593-601. (P1/108)
   Google Scholar
• Wagman R, Minsky BD, Cohen AM, Guillem JG, Paty P. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomis: long term follow-up. Int J Radiat Oncol Biol Phys 1998; 42: 51-7. (P2/36)
   Google Scholar
• Grann A, Minsky BD, Cohen AM, et al. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum 1997; 40: 515-22. (P3/32)
   Google Scholar
• Janjan NA, Khoo VS, Abbruzzese J, et al. Tumor down-staging and sphincter preservation with preoperative chemor-adiation in locally advanced rectal cancer: the MD Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 1999; 44: 1027-38. (P1/117)
   Google Scholar
• Maghfoor I, Wilkes J, Kuvshinoff B, et al. Neoadjuvant chemoradiotherapy with sphincter-sparing surgery for low lying rectal cancer. Proc Am Soc Clin Oncol 1997; 16: 274 abstr. (P3/29)
   Google Scholar
• Grann A, Feng C, Wong D, et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adeno-carcinoma. Int J Radiat Oncol Biol Phys 2001; 49: 987-95. (P1/72)
   Google Scholar
• Ngan S, Fisher R, Rischin D, et al. Comparison of two regimens of protracted infusion 5-fluorouracil as part of preoperative chemoradiation treatment of resectable adeno-carcinoma of rectum. Sixth Int Congr Radiat Oncol Radio-ther Oncol 2001; 58: 124 abstr. (P1/82)
   Google Scholar
• Tamberi S, Minguzzi N, Emiliani E, et al. Preoperative radiation therapy with concurrent 5-fluorouracil (5-FU) in continuous infusion in distal rectal cancer: preliminary results. Ann Oncol 2000; 11: 232P abstr. (P3/29)
   Google Scholar
• Russell AH, Harris J, Rosenberg PJ, et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of Radiation Therapy Oncology Group protocol 89-02. Int J Radiat Oncol Biol Phys 2000; 46: 313–22.Comment in: Int J Radiat Oncol Biol Phys 2000;46: 267-8. (P1/65)
   PubMed Web of Science ®Google Scholar
• Valentini V, Coco C, Cellini N, et al. Preoperative chemor-adiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Int J Radiat Oncol Biol Phys 1999; 45: 1175-84. (P1/83)
   Google Scholar
• Valentini V, Coco C, Cellini N, et al. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 2001; 51: 371-83. (P1/163)
   Google Scholar
• Shibata D, Guillem JG, Lanouette N, et al. Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation. Dis Colon Rectum 2000; 43: 752-8. (R2/18)
   Google Scholar
• Marijnen CAM, Kapiteijn E, van de Velde CJ, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002; 3: 817-25. (C1/1861)
   Google Scholar
• Stockholm Colorectal Cancer Study Group. Randomized study on preoperative radiotherapy in rectal carcinoma. Ann Surg Oncol 1996; 3: 423-30. (C1/849)
   Google Scholar